Patents by Inventor In Hwang KIM

In Hwang KIM has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12280081
    Abstract: A composition for preventing or treating an infection or disease caused by enterotoxigenic Bacteroides fragilis includes a Siphoviridae bacteriophage (Bac-FRP-5) having an ability to lyse the enterotoxigenic Bacteroides fragilis cells and a pharmaceutically acceptable carrier. A method for preventing or treating an infection or disease caused by enterotoxigenic Bacteroides fragilis includes administering to a subject a Siphoviridae bacteriophage and lysing the enterotoxigenic Bacteroides fragilis cells by the Siphoviridae bacteriophage.
    Type: Grant
    Filed: October 31, 2023
    Date of Patent: April 22, 2025
    Assignee: iNtRON Biotechnology, Inc.
    Inventors: Seong Jun Yoon, Jee Soo Son, In Hwang Kim, Hyoung Rok Paik, Eun Kyoung Oh, Geun Woo Lee, Soo Youn Jun, Sang Hyeon Kang
  • Patent number: 12274721
    Abstract: A composition for preventing or treating an infection or disease caused by enterotoxigenic Bacteroides fragilis includes a Siphoviridae bacteriophage (Bac-FRP-4) having an ability to lyse the enterotoxigenic Bacteroides fragilis cells and a pharmaceutically acceptable carrier. A method for preventing or treating an infection or disease caused by enterotoxigenic Bacteroides fragilis includes administering to a subject a Siphoviridae bacteriophage and lysing the enterotoxigenic Bacteroides fragilis cells by the Siphoviridae bacteriophage.
    Type: Grant
    Filed: October 31, 2023
    Date of Patent: April 15, 2025
    Assignee: iNtRON Biotechnology, Inc.
    Inventors: Seong Jun Yoon, Jee Soo Son, In Hwang Kim, Hyoung Rok Paik, Eun Kyoung Oh, Soo Youn Jun, Sang Hyeon Kang
  • Patent number: 12263196
    Abstract: A composition for preventing or treating an infection or disease caused by enterotoxigenic Bacteroides fragilis includes a Siphoviridae bacteriophage (Bac-FRP-3) having an ability to lyse the enterotoxigenic Bacteroides fragilis cells and a pharmaceutically acceptable carrier. A method for preventing or treating an infection or disease caused by enterotoxigenic Bacteroides fragilis includes administering to a subject a Siphoviridae bacteriophage and lysing the enterotoxigenic Bacteroides fragilis cells by the Siphoviridae bacteriophage.
    Type: Grant
    Filed: October 19, 2023
    Date of Patent: April 1, 2025
    Assignee: iNtRON Biotechnology, Inc.
    Inventors: Seong Jun Yoon, Jee Soo Son, In Hwang Kim, Hyoung Rok Paik, Eun Kyoung Oh, Soo Youn Jun, Sang Hyeon Kang
  • Publication number: 20240366695
    Abstract: A composition for treating an infection or disease caused by a pathogenic Escherichia coli includes a Myoviridae bacteriophage Esc-COP-23 having an ability to lyse the pathogenic Escherichia coli and a pharmaceutically acceptable carrier. A method for treating an infection or disease caused by a pathogenic Escherichia coli includes administering to a subject a Myoviridae bacteriophage and lysing the pathogenic Escherichia coli by the Myoviridae bacteriophage.
    Type: Application
    Filed: July 14, 2024
    Publication date: November 7, 2024
    Inventors: Seong Jun YOON, Jee Soo SON, In Hwang KIM, Hyoung Rok PAIK, Hyun Joo IM, Beom Seok KIM, Eun Kyoung OH, Soo Youn JUN, Sang Hyeon KANG
  • Publication number: 20240050500
    Abstract: A composition for preventing or treating an infection or disease caused by enterotoxigenic Bacteroides fragilis includes a Siphoviridae bacteriophage (Bac-FRP-5) having an ability to lyse the enterotoxigenic Bacteroides fragilis cells and a pharmaceutically acceptable carrier. A method for preventing or treating an infection or disease caused by enterotoxigenic Bacteroides fragilis includes administering to a subject a Siphoviridae bacteriophage and lysing the enterotoxigenic Bacteroides fragilis cells by the Siphoviridae bacteriophage.
    Type: Application
    Filed: October 31, 2023
    Publication date: February 15, 2024
    Inventors: Seong Jun YOON, Jee Soo SON, In Hwang KIM, Hyoung Rok PAIK, Eun Kyoung OH, Geun Woo LEE, Soo Youn JUN, Sang Hyeon KANG
  • Publication number: 20240050499
    Abstract: A composition for preventing or treating an infection or disease caused by enterotoxigenic Bacteroides fragilis includes a Siphoviridae bacteriophage (Bac-FRP-4) having an ability to lyse the enterotoxigenic Bacteroides fragilis cells and a pharmaceutically acceptable carrier. A method for preventing or treating an infection or disease caused by enterotoxigenic Bacteroides fragilis includes administering to a subject a Siphoviridae bacteriophage and lysing the enterotoxigenic Bacteroides fragilis cells by the Siphoviridae bacteriophage.
    Type: Application
    Filed: October 31, 2023
    Publication date: February 15, 2024
    Inventors: Seong Jun YOON, Jee Soo SON, In Hwang KIM, Hyoung Rok PAIK, Eun Kyoung OH, Soo Youn JUN, Sang Hyeon KANG
  • Publication number: 20240041958
    Abstract: A composition for preventing or treating an infection or disease caused by enterotoxigenic Bacteroides fragilis includes a Siphoviridae bacteriophage (Bac-FRP-3) having an ability to lyse the enterotoxigenic Bacteroides fragilis cells and a pharmaceutically acceptable carrier. A method for preventing or treating an infection or disease caused by enterotoxigenic Bacteroides fragilis includes administering to a subject a Siphoviridae bacteriophage and lysing the enterotoxigenic Bacteroides fragilis cells by the Siphoviridae bacteriophage.
    Type: Application
    Filed: October 19, 2023
    Publication date: February 8, 2024
    Inventors: Seong Jun YOON, Jee Soo SON, In Hwang KIM, Hyoung Rok PAIK, Eun Kyoung OH, Soo Youn JUN, Sang Hyeon KANG
  • Patent number: 11701398
    Abstract: A composition for preventing or treating an infection or disease caused by a pathogenic Escherichia coli includes a Podoviridae bacteriophage (Esc-COP-30) having an ability to lyse the pathogenic Escherichia coli and a pharmaceutically acceptable carrier. A method for preventing or treating an infection or disease caused by a pathogenic Escherichia coli includes administering to a subject a Podoviridae bacteriophage and lysing the pathogenic Escherichia coli by the Podoviridae bacteriophage.
    Type: Grant
    Filed: June 4, 2020
    Date of Patent: July 18, 2023
    Assignee: iNtRON Biotechnology, Inc.
    Inventors: Seong Jun Yoon, Jee Soo Son, In Hwang Kim, Hyoung Rok Paik, Hyun Joo Im, Hyun Jin Yu, Beom Seok Kim, Geun Woo Lee, Soo Youn Jun, Sang Hyeon Kang
  • Publication number: 20230159599
    Abstract: The present invention relates to an antibacterial protein CDL200 with an antibacterial activity specific against Clostridioides difficile. More specifically, the present invention relates to an antibacterial protein CDL200 specific to Clostridioides difficile that may infect and cause disease in animals including humans, the antibacterial protein CDL200 being characterized by having the ability to specifically lyse the Clostridioides difficile and containing the amino acid sequence represented by SEQ ID NO: 1. In addition, the present invention relates to a pharmaceutical composition for treating an infection or disease caused by Clostridioides difficile, the composition containing the antibacterial protein CDL200 specific to Clostridioides difficile as an active ingredient.
    Type: Application
    Filed: March 31, 2021
    Publication date: May 25, 2023
    Inventors: Seong Jun Yoon, Jee Soo Son, In Hwang Kim, Cheol Ahn, Soo Youn Jun, Sang Hyeon Kang
  • Patent number: 11596659
    Abstract: A composition for preventing or treating an infection or disease caused by a pathogenic Escherichia coli includes a Myoviridae bacteriophage Esc-COP-18 having an ability to lyse the pathogenic Escherichia coli and a pharmaceutically acceptable carrier. A method for preventing or treating an infection or disease caused by a pathogenic Escherichia coli includes administering to a subject a Myoviridae bacteriophage and lysing the pathogenic Escherichia coli by the Myoviridae bacteriophage.
    Type: Grant
    Filed: May 12, 2020
    Date of Patent: March 7, 2023
    Assignee: iNtRON Biotechnology, Inc.
    Inventors: Seong Jun Yoon, Jee Soo Son, In Hwang Kim, Hyoung Rok Paik, Hyun Joo Im, Hyun Jin Yu, Cheol Ahn, Tae Yeol Kim, Soo Youn Jun, Sang Hyeon Kang
  • Patent number: 11583565
    Abstract: A composition for preventing or treating an infection or disease caused by a pathogenic Escherichia coli includes a Myoviridae bacteriophage having an ability to lyse the pathogenic Escherichia coli and a pharmaceutically acceptable carrier. A method for preventing or treating an infection or disease caused by a pathogenic Escherichia coli includes administering to a subject a Myoviridae bacteriophage and lysing the pathogenic Escherichia coli by the Myoviridae bacteriophage.
    Type: Grant
    Filed: April 4, 2020
    Date of Patent: February 21, 2023
    Assignee: iNtRON Biotechnology, Inc.
    Inventors: Seong Jun Yoon, Jee Soo Son, In Hwang Kim, Hyoung Rok Paik, Hyun Joo Im, Ji Young Park, Hyun Jin Yu, Ji Yeong Seo, Soo Youn Jun, Sang Hyeon Kang
  • Publication number: 20220331381
    Abstract: A composition for preventing or treating an infection or disease caused by enterotoxigenic Bacteroides fragilis includes a Siphoviridae bacteriophage (Bac-FRP-5) having an ability to lyse the enterotoxigenic Bacteroides fragilis cells and a pharmaceutically acceptable carrier. A method for preventing or treating an infection or disease caused by enterotoxigenic Bacteroides fragilis includes administering to a subject a Siphoviridae bacteriophage and lysing the enterotoxigenic Bacteroides fragilis cells by the Siphoviridae bacteriophage.
    Type: Application
    Filed: April 10, 2021
    Publication date: October 20, 2022
    Inventors: Seong Jun YOON, Jee Soo SON, In Hwang KIM, Hyoung Rok PAIK, Eun Kyoung OH, Geun Woo LEE, Soo Youn JUN, Sang Hyeon KANG
  • Publication number: 20220323518
    Abstract: A composition for preventing or treating an infection or disease caused by enterotoxigenic Bacteroides fragilis includes a Siphoviridae bacteriophage (Bac-FRP-4) having an ability to lyse the enterotoxigenic Bacteroides fragilis cells and a pharmaceutically acceptable carrier. A method for preventing or treating an infection or disease caused by enterotoxigenic Bacteroides fragilis includes administering to a subject a Siphoviridae bacteriophage and lysing the enterotoxigenic Bacteroides fragilis cells by the Siphoviridae bacteriophage.
    Type: Application
    Filed: April 10, 2021
    Publication date: October 13, 2022
    Inventors: Seong Jun YOON, Jee Soo SON, In Hwang KIM, Hyoung Rok PAIK, Eun Kyoung OH, Soo Youn JUN, Sang Hyeon KANG
  • Publication number: 20220323517
    Abstract: A composition for preventing or treating an infection or disease caused by enterotoxigenic Bacteroides fragilis includes a Siphoviridae bacteriophage (Bac-FRP-3) having an ability to lyse the enterotoxigenic Bacteroides fragilis cells and a pharmaceutically acceptable carrier. A method for preventing or treating an infection or disease caused by enterotoxigenic Bacteroides fragilis includes administering to a subject a Siphoviridae bacteriophage and lysing the enterotoxigenic Bacteroides fragilis cells by the Siphoviridae bacteriophage.
    Type: Application
    Filed: April 10, 2021
    Publication date: October 13, 2022
    Inventors: Seong Jun YOON, Jee Soo SON, In Hwang KIM, Hyoung Rok PAIK, Eun Kyoung OH, Soo Youn JUN, Sang Hyeon KANG
  • Publication number: 20220105142
    Abstract: A composition for preventing or treating an infection or disease caused by a pathogenic Escherichia coli includes a Myoviridae bacteriophage (Esc-COP-23) having an ability to lyse the pathogenic Escherichia coli and a pharmaceutically acceptable carrier. A method for preventing or treating an infection or disease caused by a pathogenic Escherichia coli includes administering to a subject a Myoviridae bacteriophage and lysing the pathogenic Escherichia coli by the Myoviridae bacteriophage.
    Type: Application
    Filed: October 1, 2020
    Publication date: April 7, 2022
    Inventors: Seong Jun YOON, Jee Soo SON, In Hwang KIM, Hyoung Rok PAIK, Hyun Joo IM, Beom Seok KIM, Eun Kyoung OH, Soo Youn JUN, Sang Hyeon KANG
  • Publication number: 20210379128
    Abstract: A composition for preventing or treating an infection or disease caused by a pathogenic Escherichia coli includes a Podoviridae bacteriophage (Esc-COP-30) having an ability to lyse the pathogenic Escherichia coli and a pharmaceutically acceptable carrier. A method for preventing or treating an infection or disease caused by a pathogenic Escherichia coli includes administering to a subject a Podoviridae bacteriophage and lysing the pathogenic Escherichia coli by the Podoviridae bacteriophage.
    Type: Application
    Filed: June 4, 2020
    Publication date: December 9, 2021
    Inventors: Seong Jun YOON, Jee Soo SON, In Hwang KIM, Hyoung Rok PAIK, Hyun Joo IM, Hyun Jin YU, Beom Seok KIM, Geun Woo LEE, Soo Youn JUN, Sang Hyeon KANG
  • Publication number: 20210353695
    Abstract: A composition for preventing or treating an infection or disease caused by a pathogenic Escherichia coli includes a Myoviridae bacteriophage (Esc-COP-18) having an ability to lyse the pathogenic Escherichia coli and a pharmaceutically acceptable carrier. A method for preventing or treating an infection or disease caused by a pathogenic Escherichia coli includes administering to a subject a Myoviridae bacteriophage and lysing the pathogenic Escherichia coli by the Myoviridae bacteriophage.
    Type: Application
    Filed: May 12, 2020
    Publication date: November 18, 2021
    Inventors: Seong Jun YOON, Jee Soo SON, In Hwang KIM, Hyoung Rok PAIK, Hyun Joo IM, Hyun Jin YU, Cheol AHN, Tae Yeol KIM, Soo Youn JUN, Sang Hyeon KANG
  • Publication number: 20210308198
    Abstract: A composition for preventing or treating an infection or disease caused by a pathogenic Escherichia coli includes a Myoviridae bacteriophage having an ability to lyse the pathogenic Escherichia coli and a pharmaceutically acceptable carrier. A method for preventing or treating an infection or disease caused by a pathogenic Escherichia coli includes administering to a subject a Myoviridae bacteriophage and lysing the pathogenic Escherichia coli by the Myoviridae bacteriophage.
    Type: Application
    Filed: April 4, 2020
    Publication date: October 7, 2021
    Inventors: Seong Jun YOON, Jee Soo SON, In Hwang KIM, Hyoung Rok PAIK, Hyun Joo IM, Ji Young PARK, Hyun Jin YU, Ji Yeong SEO, Soo Youn JUN, Sang Hyeon KANG